HSN Code 30021500: Immunological Products (Retail Pack)

HSN Code 30021500 represents Immunological Products (Retail Pack) under GST classification. This code helps businesses identify Immunological Products (Retail Pack) correctly for billing, taxation, and trade. With HSN Code 30021500, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import or export of Immunological Products (Retail Pack).

Live Demo Available Today

Experience the power of Expert Accounting

Join our guided walkthrough to see how BUSY can transform your business operations.

Trusted by 6,00,000+ Users
4.6 Google Rating
+91
expand_more

* No credit card required

Description of Goods for HSN Code 30021500

HSN Code 30021500 relates to the following description.

Description of Goods

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, put up in measured doses or in forms or packings for retail sale

Chapter

30 - Pharmaceutical products

Sub Chapter

3002 - Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified

CGST

6%

SGST

6%

IGST

12%

CESS

0%

What does HSN Code 30021500 not include?

Immunological Products (Retail Pack) does not include products with the following descriptions.

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for diptheria

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for snake venom

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : hemoglobin blood globulins and serum globulins

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : of human origin

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For diphtheria

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For tetanus

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For rabies

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For Snake venom

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : antisera: Other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale:

Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for cholera and typhoid

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for hepatitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for polio

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tuberculosis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for japanese encephalitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for whopping cough (pertusis)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria, pertusis and tetanus (dpt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria and tetanus (dt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for measles, mumps and rubella (mmr)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for typhoid-paratyphoid (tab) or typhoid- paratyphoid-cholera (tabc)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Cholera and typhoid

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Hepatitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tetanus

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Polio

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tuberclosis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Rabies

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Japanese encephalitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Whopping cough (pertussis)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria, pertussis and tetanus (DPT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria and tetanus (DT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Measles, mumps and rubella (MMR)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid (TAB)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid-cholera (TABC)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Cultures of micro-organisms (excluding yeast)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Toxins

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other

Other : Animal blood prepared for therapeutic, prophylactic or diagnostic uses

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : cultures of micro-organisms (excluding yeast)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : toxins

India’s Trade Performance — HSN Code 30021500 in FY 2024-25

TradeStat EIDB — Ministry of Commerce & Industry FY 2018-19–FY 2024-25 Values in ₹ Crore

India’s Exports

FY 2024-25

₹2,589 Cr

+13.84% vs FY 2023-24

0.0703% of India’s total exports

India’s Imports

FY 2024-25

₹4,791 Cr

+90.97% vs FY 2023-24

0.0788% of India’s total imports

Trade Balance

FY 2024-25

−₹2,202 Cr

Trade Deficit

Surplus rank #12435 of 12657 HSN codes

% of Sub-Chapter 3002

FY 2024-25

17.18%

Share of Sub-Chapter 3002’s total exports in FY 2024-25

Import side: 43.42% of Sub-Chapter 3002’s imports

Rank Within Sub-Chapter 3002

FY 2024-25

#3 of 61

Position by export value among HSN codes in Sub-Chapter 3002

Import-side rank: #1 of 61

At a glance

26.82%

Export CAGR

FY 2018-19 → FY 2024-25 · 7 fiscal years

#204

National Export Rank

of 12657 HSN codes by export value, FY 2024-25

+48.00%

Peak Growth Year

FY 2020-21 · strongest single-year move

17.18%

Contribution to Sub-Ch. 3002

Share of Sub-Chapter 3002 exports in FY 2024-25

India Export-Import Trade Statistics for HSN Code 30021500

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

FY 2018-19 Exp. Rank #528

Balance

−222.18

Exports

622.23 ₹ Cr

0.0272% share

YoY

10.16% of Sub-Ch. 3002

Imports

844.41 ₹ Cr

0.0236% share

YoY

15.88% of Sub-Ch. 3002

FY 2019-20 Exp. Rank #377

Balance

−329.16

Exports

872.12 ₹ Cr

0.0396% share

+40.16% YoY

11.70% of Sub-Ch. 3002

Imports

1,201.28 ₹ Cr

0.0359% share

+42.26% YoY

17.47% of Sub-Ch. 3002

FY 2020-21 Exp. Rank #267

Balance

+15.90

Exports

1,290.77 ₹ Cr

0.0600% share

+48.00% YoY

14.21% of Sub-Ch. 3002

Imports

1,274.87 ₹ Cr

0.0438% share

+6.13% YoY

14.94% of Sub-Ch. 3002

FY 2021-22 Exp. Rank #307

Balance

−440.03

Exports

1,582.27 ₹ Cr

0.0504% share

+22.58% YoY

14.49% of Sub-Ch. 3002

Imports

2,022.30 ₹ Cr

0.0442% share

+58.63% YoY

22.19% of Sub-Ch. 3002

FY 2022-23 Exp. Rank #284

Balance

−936.46

Exports

1,807.40 ₹ Cr

0.0499% share

+14.23% YoY

15.33% of Sub-Ch. 3002

Imports

2,743.86 ₹ Cr

0.0477% share

+35.68% YoY

32.84% of Sub-Ch. 3002

FY 2023-24 Exp. Rank #215

Balance

−234.58

Exports

2,273.92 ₹ Cr

0.0628% share

+25.81% YoY

16.32% of Sub-Ch. 3002

Imports

2,508.50 ₹ Cr

0.0447% share

−8.58% YoY

29.39% of Sub-Ch. 3002

FY 2024-25 Exp. Rank #204

Balance

−2,202.06

Exports

2,588.54 ₹ Cr

0.0703% share

+13.84% YoY

17.18% of Sub-Ch. 3002

Imports

4,790.60 ₹ Cr

0.0788% share

+90.97% YoY

43.42% of Sub-Ch. 3002

CAGR · 7-Year

Exports

26.82% /yr

Imports

33.55% /yr

Consistently Deficit
Sub-Chapter 3002 total

reference, FY 2024-25

Export

₹15,063.17 Cr

Import

₹11,034.41 Cr

Trade Balance

+4,028.76

Peak export growth year Latest available data Not available YoY = change vs previous FY

Key Trade Insights: HSN Code 30021500 Export-Import Analysis

Consistent Export Growth: 26.82% CAGR Over 7 Years

India's exports under HSN Code 30021500 have grown at a compound annual rate of 26.82% over 7 fiscal years, rising from ₹622.23 Crore in FY 2018-19 to ₹2,588.54 Crore in FY 2024-25.

HSN Code 30021500 Ranked #204 Among All 12657 HSN codes by Export Value

In FY 2024-25, HSN Code 30021500 ranks #204 out of 12657 HSN codes by total export value. Within Sub-Chapter 3002, it ranks #3 of 61. By trade surplus, it ranks #12435 of 12657.

FY 2020-21 Was the Strongest Growth Year for HSN Code 30021500 Exports

The strongest single-year export movement for HSN Code 30021500 was recorded in FY 2020-21, when exports surged by 48.00% over the prior year.

India Records a Trade Deficit of ₹2,202.06 Crore in HSN Code 30021500 Goods

In FY 2024-25, India's imports of ₹4,790.60 Cr exceeded exports of ₹2,588.54 Cr, resulting in a trade deficit of ₹2,202.06 Crore — ranking #12435 of 12657 by surplus magnitude.

Import Growth of 33.55% CAGR Signals Rising Demand for Immunological Products (Retail Pack)

India's imports under HSN Code 30021500 have grown at 33.55% CAGR, reaching ₹4,790.60 Crore in FY 2024-25.

HSN Code 30021500 Contributes 17.18% of Sub-Chapter 3002 Exports — Ranked #3

Among the 61 HSN codes under Sub-Chapter 3002, HSN Code 30021500 ranks #3 by export value — accounting for 17.18% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 43.42% share (rank #1).

Stop worrying about HSN & TAX compliance

BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.

Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
+91
expand_more

* No credit card required

Frequently Asked Questions

Clear answers to common queries about HSN Code 30021500 and GST compliance.

What products are classified under HSN 30021500 ?

It includes Immunological Products (Retail Pack)

Does packaging or labelling change the GST for Immunological Products (Retail Pack)?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

Can we claim ITC on inputs used to trade Immunological Products (Retail Pack)?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

How much GST applies to Immunological Products (Retail Pack)?

Under HSN 30021500, Immunological Products (Retail Pack) attracts Varies when sold in taxable form. Describe the exact form on the invoice.

How should mixed supplies be billed when Immunological Products (Retail Pack) is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Immunological Products (Retail Pack); Nil for exempt items if applicable).

Any common misclassification issue with Immunological Products (Retail Pack)?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

Important Disclaimer

The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.